In addition, we investigated the role of SMYD3 in tumor development and progression in vivo by subcutaneously implanting LM3 cells that had been engineered to stably express SMYD3 shRNA or control scrambled shRNA into athymic BALB/c mice. The gene discussed is SMYD3; the disease is neoplasm.